‍🔬 Mercy BioAnalytics Raises $59M Series B for Early Cancer Detection

Funding supports blood-based ovarian cancer test commercialization.‍

"We believe Mercy is building one of the most promising early detection platforms in oncology. Their technology addresses a critical gap in current cancer screening, and we're excited to support the team as they continue to deliver on critical regulatory, clinical, and commercial milestones."

— Paul Meister, Partner, Novalis

🔗 Read More

‍

💰 Aspira Women's Health Announces $3.06M Equity Capital Infusion

Funding supports commercial activities for gynecologic diagnostics.

🔗 Read More

‍

🏥 Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge

FDA registration enables U.S. market entry for AI-powered diagnostics.‍

"We appreciate the commitment and confidence these investors have placed in our team. This important capital infusion can propel the Company forward as we execute on our growth plans and unlock tremendous value solving some of the most pressing unmet needs in women's health today."

— Jack Fraser, Chairman, Aspira Women's Health

🔗 Read More

‍‍

🤝 Temasek Foundation and UNICEF Venture Announce Femtech Partnership

Partnership targets femtech startups in Southeast Asia.

🔗 Read More‍

‍

⚖️ Google and Flo Health Agree to $56M Privacy Settlement

Settlement resolves menstrual health data collection claims.

🔗 Read More‍

‍

📱 Clue and Withings Join Forces for Comprehensive Women's Health Tracking

Partnership integrates health monitoring with cycle tracking.

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.  

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!